Search results
Results from the WOW.Com Content Network
In September 2010, Novartis agreed to pay US$422.5 million in criminal and civil claims and to enter into a corporate integrity agreement with the US Office of the Inspector General. [190] According to The New York Times , "Federal prosecutors accused Novartis of paying illegal kickbacks to health care professionals through speaker programs ...
The property is now owned by DFS Advisors, and is under long-term lease to Novartis. The complex, which includes the factory building, a power plant, and a modern (2003) parking garage, occupies most of an entire city block bounded by Massachusetts Avenue, Cross Street, Albany Street, and Lansdowne Street.
5 United States. 6 Elsewhere. 7 See also. ... This page is a list of pages listing corporate headquarters and corporations headquartered in particular cities. Canada
In 2015, the company substantially expanded its intellectual property holdings through complete acquisition of the full RNAi research and development portfolio, and assets from Novartis. [4] [5] In April 2016, the company announced a name change from Arrowhead Research Corporation to Arrowhead Pharmaceuticals, Inc. [6]
Novartis CEO Vas Narasimhan has been vocal about the pressure the drug industry is facing both in the U.S. and in Europe, but he argues the Inflation Reduction Act and Europe's proposed patent ...
The company was founded in 1992. In 1999, MorphoSys listed on the Frankfurt Stock Exchange under the ticker symbol "MOR". In 2004, MorphoSys and Novartis entered into a strategic partnership for the research and development of biopharmaceuticals, which was expanded in 2007. [1]
It had offices and facilities in eighteen countries on five continents. Chiron's business and research was in three main areas: biopharmaceuticals , vaccines , and blood testing . Chiron's vaccines and blood testing units were combined to form Novartis Vaccines and Diagnostics, while Chiron BioPharmaceuticals was integrated into Novartis ...
Advanced Accelerator Applications (AAA or Adacap) is a France-based pharmaceutical group, specialized in the field of nuclear medicine. [1] The group operates in all three segments of nuclear medicine (PET, SPECT and therapy) to diagnose and treat serious conditions in the fields of oncology, neurology, cardiology, infectious and inflammatory diseases.